Meningococcal vaccine groups A C W135 and Y polysaccharide (Pfizer)

N/A

Report date: 2023/06/01 20:00:46

Base Information

Drug NameMeningococcal vaccine groups A C W135 and Y polysaccharide (Pfizer)
Drug Alias NameACWY VaxACYW135็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็–ซ่‹—ๅ››ไปท่„‘่†œ็‚Ž็ƒ่ŒACWYๅคš็ณ–็–ซ่‹—Mencevax ACWYSerogroups A, C, W-135 and Y polysaccharide meningococcal vaccine +[7]ย 
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsMeningococcal Infections

Other Information

ATC CodeN/A
Related LinksWikipedia